News

As President Trump intensifies his battle with German Chancellor Angela Merkel over trade and NATO policies, he should pause to consider the lessons from another German Chancellor-Otto von Bismarck.

A pharma maker is voluntarily recalling several lots of a major heart medication. Here’s why.

As Amazon’s PillPack acquisition threatens pharmacies, CVS Health snaps back with its membership program, CarePass. Here’s how experts say it will affect managed care.

Mobile technologies offer opportunities to engage members, improve chronic care management, and prevent avoidable hospital admissions and readmissions.

Results of 20-year cohort study reveal that women with history of this serious medical illness are more vulnerable to lupus.

It can be tricky for individuals with this condition to effectively tackle their diabetes. Here’s how healthcare executives can help.

Patients must first get over these hurdles to achieve healthy outcomes. Here's how you can help.

Preventable hospital readmissions, an objective measure of quality, have long been a concern for health plans. Here’s a care plan that could be the solution.

FDA recently stopped importation and sent warning letters to numerous online sellers of illegal opioids, oncology drugs and other medicines.

Early results from a first-of-its-kind study suggests that typical use of a fertility app is effective for avoiding an unplanned pregnancy. Payment mechanisms will need to be considered by payers.

Good leaders don’t just rely on one managerial style-they get the best out of every team member by meeting their needs.

A survey from Vizient identifies top strategies for the treatment of pain.

Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.

It can be challenging for patients with schizophrenia to keep to a medication regimen-here are the reasons why it’s important to invest in strategies to help them stay compliant.

Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.

A novel treatment for patients with moderate-to-severe asthma is now on the market.

A new indication for rivaroxaban (Xarelto) has been approved by FDA.

A survey from insuranceQuotes.com has surprising findings about open enrollment and the ACA.

Home non-invasive ventilation supports longer lives, fewer readmissions, and lower costs than other devices, based on findings of a KPMG study.

Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.

Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

With healthcare being a key issue in the midterm elections, here are 11 things healthcare executives should keep in mind.

A new study was conducted to better understand the landscape of coverage of non-pharmacologic treatments for chronic pain among public and private insurers in the United States. Here’s what it found.

UPMC Health Plan has recently entered into two value-based contracts for medications related to treating diabetes and opioid addiction.

The launch of a new connected health platform will aid in management of diseases such as diabetes.

FDA approved a new antibiotic to treat community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI).